GPRC6A and fatty liver disease: A potential function of GPRC6A in the liver is suggested by the presence of hepatosteatosis in Gprc6a−/− mice10 and pharmacological actions of Ocn administration to prevent high fat diet induced fatty liver disease in mice10,17–19.